Abstract:Immunotherapy has shown great promise for the treatment of cancer. However, the limited efficacy of single‐agent immunotherapy hinders its widespread application, which stimulated the investigation of combination therapy with improved efficacy. Herein, a tri‐functional immunostimulatory supramolecular nanomedicine consisting of indoximod (IND, an indoleamine 2,3‐dioxygenase (IDO) inhibitor), DPPA‐1 (a D‐peptide antagonist against programmed cell death ligand‐1 (PD‐L1)), and a self‐assembling D‐tetrapeptide of GDFDFDY (a powerful adjuvant with immunostimulatory properties) is reported. The resulting IND‐GDFDFDY‐DPPA‐1 behaves as a supramolecular “trident,” and its three functional parts play parallel roles to boost the effective immune responses. It is shown that the supramolecular “trident” exhibits a stronger binding ability to PD‐L1 than the DPPA‐1 peptide (>fourfold) and is able to inhibit the IDO‐1 pathway more efficiently than IND itself. The supramolecular “trident” activates and recruits the cytotoxic CD8+ T lymphocytes along with other immune effector cells in tumors, concomitant with downregulation of Foxp3+ T cells and upregulation of tumor immune‐related cytokines, thus showing a strong ability to improve the tumor microenvironment and enhance immunotherapeutic effects to prevent tumor growth and metastasis in the breast tumor model. The findings may stimulate the development of self‐assembling peptide‐based multifunctional nanomedicines for cancer therapy. A tri‐functional immunostimulatory supramolecular nanomedicine, bearing the IDO inhibitor, PD‐L1 blockade, and assembling tetra‐peptide immune adjuvant is developed and applied for cancer immunotherapy. It significantly improves the tumor microenvironments and thus shows a superior capacity to inhibit tumor growth.

Triply Enhanced Immunotherapy via Dual Glycan Reforming Integrated with Perforation

Bimetallic Peroxide-Based Nanotherapeutics for Immunometabolic Intervention and Induction of Immunogenic Cell Death to Augment Cancer Immunotherapy

Tumor Microenvironment-Modulated Multiple Nanotherapeutic System for Potent Cancer Immunotherapy and Metastasis Inhibition

Combination of GNRs-PEI/cGAMP-laden Macrophages-Based Photothermal Induced in Situ Tumor Vaccines and Immune Checkpoint Blockade for Synergistic Anti-Tumor Immunotherapy.

Strengthening the Combinational Immunotherapy from Modulating the Tumor Inflammatory Environment via Hypoxia-Responsive Nanogels

Triple-Combination Immunogenic Nanovesicles Reshape the Tumor Microenvironment to Potentiate Chemo-Immunotherapy in Preclinical Cancer Models

Ultra‐Galactocation to Sialic Acid on Tumor Cells with A Penta‐Functional Dendritic Probe for Enhanced Immuno‐Killing

Stepwise Targeting and Tandem Responsive Peptide Nanoparticles Enhance Immunotherapy through Prolonged Drug Retention

Tumor microenvironment reprogramming combined with immunogenic enhancement by nanoemulsions potentiates immunotherapy

Pore forming–mediated intracellular protein delivery for enhanced cancer immunotherapy

Ultra‐Galactocation to Sialic Acid on Tumor Cells with A Penta‐Functional Dendritic Probe for Enhanced Immune‐Killing

Trinity immune enhancing nanoparticles for boosting antitumor immune responses of immunogenic chemotherapy

Unlocking the power of immunotherapy: Combinatorial delivery of plasmid IL-15 and gemcitabine to synergistically remodeling the tumor microenvironment

Biodegradable Nanoparticles-Mediated Targeted Drug Delivery Achieves Trans-Spatial Immunotherapy

A Supramolecular “Trident” for Cancer Immunotherapy

Induction of therapeutic immunity and cancer eradication through biofunctionalized liposome-like nanovesicles derived from irradiated-cancer cells

Synergistic Transcutaneous Immunotherapy Enhances Antitumor Immune Responses through Delivery of Checkpoint Inhibitors.

Dual-mechanism based CTLs infiltration enhancement initiated by Nano-sapper potentiates immunotherapy against immune-excluded tumors

Promoting The Recruitment, Engagement, And Reinvigoration of Effector T Cells via An Injectable Hydrogel with A Supramolecular Binding Capability for Cancer Immunotherapy

Enhancing cancer chemo-immunotherapy by biomimetic nanogel with tumor targeting capacity and rapid drug-releasing in tumor microenvironment

Dual mitigation of immunosuppression combined with photothermal inhibition for highly effective primary tumor and metastases therapy